Rosiglitazone (Avandia - brand name) - Yet another drug that increases the risk of heart attack. In Europe, Avandia has been withdrawn from the market in the US, to severely control its use, after a 3 year review of its heart attacks.

Rosiglitazone, marketed by GSK as Avandia, has been used to treat Type 2 diabetes.

Patients with Type 1 diabetes cannot produce insulin at all.

Patients with Type 2 diabetes are resistant to the effects of insulin.

Insulin is a hormone that controls the amount of glucose in the blood. Rosiglitazone increases insulin sensitivity, controlling blood sugar levels and hence helps type 2 diabetic patients.

Labels: Diabetes

about me

• ♥Missy Cai
• an ex-clinic assistant who shares her views and her little medical knowledge.

recent records

• Rheumatoid Arthritis
• Proper procedure of cleansing wounds
• Why does this Panadol act faster?
• Constipation and Bisacodyl
• Gout no longer just rich man's disease
• Xyzal and Zyrtec, same or different?
• How Full Blood Count tells about Dengue
• Medical Humour #1
• Cessation of the marketing of Mediaxal
• Do you have High Blood Pressure?

I say

• In life, you can never have everything you want. But you can make the best out of what you have.

patients' messages

• Blogwalkers are sick.

past medical history

health topics and diagnosis

• Anti-histamine
• Constipation
• CPR - Cardiopulmonary Resuscitation
• Dengue Fever
• Diabetes
• Eye
• Gout
• Heart Attack
• Heart Valve Disease
• High Blood Pressure
• Logorrhea
• Mania
• Medical Examination
• Mental Illness
• Miscelleneous News
• Obesity
• Parkinson's Disease
• Rheumatoid Arthritis
• Sensitive Nose
• Stroke
• URTI - Upper Respiratory Tract Infection
• Wound Dressing
• Medical Humour

disclaimer

• This blog is intended for my own learning and reference only and does not serve as professional medical advice. It's always best to consult your doctor prior to initiating any form of medical regimen and treatment.